The significance of νо gas transmitter and nucleases in shaping the sequelae of traumatic brain injury


Journal

Wiadomosci lekarskie (Warsaw, Poland : 1960)
ISSN: 0043-5147
Titre abrégé: Wiad Lek
Pays: Poland
ID NLM: 9705467

Informations de publication

Date de publication:
31 Oct 2019
Historique:
entrez: 27 1 2020
pubmed: 27 1 2020
medline: 31 1 2020
Statut: ppublish

Résumé

Traumatic brain injuries are at present remaining an important worldwide medical problem due to substantial percentages of incapacitation and lethality, especially among people of working age. All therapeutic interventions in TBI and their timeliness and efficacy depend on timely and quality diagnosis of patient’s condition, including laboratory parameters of blood and urine. The aim: To assess for peculiar patterns in changes of NO gas transmitter levels in patients with severe traumatic brain injury during the treatment period and to investigate into its relationship with nuclease enzymes in the context of various treatment outcomes. This research work has used clinical data, history and diagnostic tests obtained in 72 patients with severe traumatic brain injury, age 18 to 76 years (mean age 42.26±15.02 years), who six months later have been divided into the following four groups according to Glasgow outcome scale: “Death”, “Severe disability”, “Moderate disability” and “Recovery”. Biochemical assessments in patients with severe traumatic brain injury have shown supranormal levels of urinary nitric oxide and serum DNAses. Going forward, nitric oxide levels significantly decreased over the time of treatment in subjects with favorable outcomes (“Moderate disability” and “Recovery” groups) and increased with treatment time in subjects with unfavorable outcomes (“Severe disability” and “Death” groups). The diagnostic markers of further unfavorable survival outcomes may be present at the onset of treatment (Day 1) and may include urinary levels of nitric oxide below 1.1 μmol/L and DNAse levels below 26 μU/mL. A positive diagnostic sign of favorable survival and health outcomes may include DNAse І levels over 30.0 μU/mL from Day 7 of treatment. The findings of this work can be used when making a diagnosis/selecting an optimal treatment schedule and predicting the sequelae of traumatic brain injury in a patient, which may cumulatively minimize the impact of the injury.

Identifiants

pubmed: 31982009

Types de publication

Journal Article

Langues

eng

Pagination

1894-1899

Auteurs

Oleh Kobyletskyi (O)

Department of Neuropathology and Neurosurgery, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Andrii Netliukh (A)

Department of Neuropathology and Neurosurgery, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Nataliya Matolinets (N)

Department of Anesthesiology and Intensive Care, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Andrii Kulmatytskyi (A)

Department of Neuropathology and Neurosurgery, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Oksana Kovalska (O)

Department of Social Medicine, Economics and Organization of Health Care, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Dzvenislava Moskviak-Lesniak (D)

Department of Social Medicine, Economics and Organization of Health Care, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Taras Gutor (T)

Department of Social Medicine, Economics and Organization of Health Care, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH